SkGel implant provides stable IOP

Article

Deep sclerectomy with the SkGel implant (Corneal Laboratories) provides stable, long-term control of intraocular pressure (IOP) and visual field .

Deep sclerectomy with the SkGel implant (Corneal Laboratories) provides stable, long-term control of intraocular pressure (IOP) and visual field (VF), according to a report in the January/February issue of the Journal of Glaucoma.

Fernando Galassi and Barbara Giambene from the University of Florence, Florence, Italy evaluated the results of deep sclerectomy with the SkGel implant, a biodegradable cross-linked sodium hyaluronate drainage implant, at three and five years.

The retrospective trial included 200 eyes with open-angle glaucoma which had three years of follow-up and 97 eyes which had five years of follow-up. Mean IOP decreased from 21.01±5.56 mmHg prior to surgery to 13.13±2.24 mmHg at 36 months follow-up, and from 20.61±5.50 mmHg to 13.85±1.84 mmHg at 60 months follow-up (p<0.0005).

At three and five years, complete success rates (IOP ≤16 mmHg without medications) were 67.50% and 64.95%, partial success rates (IOP ≤16 mmHg with medications) were 21.50% and 24.74% and failure rates (IOP >16 mmHg) were 11% and 10.31%, respectively. Visual field testing revealed stable mean deviation and corrected pattern standard deviation values at three and five years (p>0.05).

This study demonstrates that deep sclerectomy with the SkGel implant results in stable long-term IOP and visual field.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.